Usana Health Sciences Inc(USNA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.2 | Insider Own | 40.92% | Shs Outstand | 18.5M | Perf Week | 1.85% |
| Market Cap | 0.27B | Forward P/E | 8.38 | EPS next Y | 132.89% | Insider Trans | -0.44% | Shs Float | 10.9M | Perf Month | 7.78% |
| Enterprise Value | 0.15B | PEG | - | EPS next Q | 0.11 | Inst Own | 62.07% | Short Float | 6.93% | Perf Quarter | -22.64% |
| Income | -0.02B | P/S | 0.3 | EPS this Y | -60.62% | Inst Trans | 13.13% | Short Ratio | 4.48 | Perf Half Y | -15.79% |
| Sales | 0.91B | P/B | 0.52 | EPS next 5Y | - | ROA | -3.08% | Short Interest | 0.76M | Perf YTD | -24.45% |
| Book/sh | 28.51 | P/C | 1.63 | EPS past 3/5Y | -45.56% -37.06% | ROE | -4.19% | 52W High | -52.39% ($31.15) | Perf Year | -50.8% |
| Cash/sh | 9.12 | P/FCF | 17.2 | Sales past 3/5Y | -2.51% -4% | ROIC | -4.21% | 52W Low | 17.98% ($12.57) | Perf 3Y | -74.61% |
| Dividend Est. | - | EV/EBITDA | 1.87 | EPS Y/Y TTM | -166.61% | Gross Margin | 73.9% | Volatility(W/M) | 5% 4.68% | Perf 5Y | -84.85% |
| Dividend TTM | - | EV/Sales | 0.16 | Sales Y/Y TTM | 1.57% | Oper. Margin | 4.54% | ATR (14) | 0.8 | Perf 10Y | -78.39% |
| Dividend Ex-Date | - | Quick Ratio | 1.84 | EPS Q/Q | -322.06% | Profit Margin | -2.43% | RSI (14) | 44.96 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.66 | Sales Q/Q | -5.33% | SMA20 | 6.1% ($13.98) | Beta | 0.67 | Target Price | $25 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/8/4 | SMA50 | -17.28% ($17.93) | Rel Volume | 0.96 | Prev Close | $15.12 |
| Employees | 1570 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -116.28% -4.99% | SMA200 | -22.18% ($19.06) | Avg Volume(3M) | 0.17M | Price | $14.83 |
| IPO | 1996/5/30 | Option/Short | Yes/Yes | Trades | 3716 | Volume | 161,211 | Change | -1.92% |
Company
USNA is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🌿 A global health functional food company that supplies science-based nutritional supplements through direct selling (network marketing). Headquartered in the US, it operates in around 20 countries, with vertical integration via its own manufacturing facilities and an extensive independent distributor network serving as its core competitive strengths.
Over the past 1 year, on the lower side
52% below its 1-year high.
USNA has weak earning power
4.54% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -60.6% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -74.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 62.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DEEP 0.01%
SIXS 0.01%
LQPE 0.00%
SQLV 0.00%
AFSM 0.00%It ranks #4 in the industry
Based on market cap of $274M.
USNA $274M PER -
KHC $29B PER -
GIS $19B PER -
MKC $14B PER 8.5
FAQ
What kind of company is USNA?
USNA belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of USNA?
The market cap of USNA is approximately $274M, ranking 3,835 within its sector.
What is the 52-week high and low for USNA?
USNA has recorded a 52-week high of $31.15 and a low of $12.57.
